{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:47:43Z","timestamp":1782179263124,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["U24DA048538"],"award-info":[{"award-number":["U24DA048538"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["UH3DA044822"],"award-info":[{"award-number":["UH3DA044822"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["UH3DA044822"],"award-info":[{"award-number":["UH3DA044822"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["UG3DA044829"],"award-info":[{"award-number":["UG3DA044829"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["U24DA048538"],"award-info":[{"award-number":["U24DA048538"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["U24DA048538"],"award-info":[{"award-number":["U24DA048538"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["UG3DA044830"],"award-info":[{"award-number":["UG3DA044830"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["UG3DA044831"],"award-info":[{"award-number":["UG3DA044831"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["U24DA048538"],"award-info":[{"award-number":["U24DA048538"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["U24DA048538"],"award-info":[{"award-number":["U24DA048538"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["U24DA048538"],"award-info":[{"award-number":["U24DA048538"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["UG3DA044798"],"award-info":[{"award-number":["UG3DA044798"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["UG3DA044826"],"award-info":[{"award-number":["UG3DA044826"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["UG3DA044823"],"award-info":[{"award-number":["UG3DA044823"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["UG3DA044829"],"award-info":[{"award-number":["UG3DA044829"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["UG3DA044830"],"award-info":[{"award-number":["UG3DA044830"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-026-01460-8","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:17:15Z","timestamp":1777724235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transitions from first drug use to illicit opioid and injection drug use in a multisite rural U.S. cohort of people who use drugs"],"prefix":"10.1186","volume":"23","author":[{"given":"Rob J.","family":"Fredericksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adams","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiley","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Sarah","family":"Mixson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget M.","family":"Whitney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.C.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith I.","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Zule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Seal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"1460_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183\u20138.","journal-title":"Int J Drug Policy"},{"issue":"Pt 2","key":"1460_CR2","doi-asserted-by":"publisher","first-page":"106541","DOI":"10.1016\/j.ypmed.2021.106541","volume":"152","author":"RA Jenkins","year":"2021","unstructured":"Jenkins RA. The fourth wave of the US opioid epidemic and its implications for the rural US: A federal perspective. Prev Med. 2021;152(Pt 2):106541.","journal-title":"Prev Med"},{"issue":"4","key":"1460_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344\u201350.","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"1460_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","volume":"110","author":"TJ Cicero","year":"2020","unstructured":"Cicero TJ, Ellis MS, Kasper ZA. Polysubstance use: a broader understanding of substance use during the opioid crisis. Am J Public Health. 2020;110(2):244\u201350.","journal-title":"Am J Public Health"},{"issue":"5","key":"1460_CR5","doi-asserted-by":"publisher","first-page":"e250809","DOI":"10.1001\/jamahealthforum.2025.0809","volume":"6","author":"D Powell","year":"2025","unstructured":"Powell D, Jacobson M. Estimates of illicit opioid use in the US. JAMA Health Forum. 2025;6(5):e250809.","journal-title":"JAMA Health Forum"},{"key":"1460_CR6","unstructured":"Statistics NCfH. U.S. overdose deaths decrease almost 27% in 2024. Centers for Disease Control. 2025 May 14, 2025."},{"issue":"48","key":"1460_CR7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.15585\/mmwr.mm7348a2","volume":"73","author":"LJ Tanz","year":"2024","unstructured":"Tanz LJ, Stewart A, Gladden RM, Ko JY, Owens L, O\u2019Donnell J. Detection of illegally manufactured fentanyls and carfentanil in drug overdose deaths - United States, 2021\u20132024. MMWR Morb Mortal Wkly Rep. 2024;73(48):1099\u2013105.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1460_CR8","doi-asserted-by":"publisher","DOI":"10.7249\/RR3117","volume-title":"Stein, B.D. The future of fentanyl and other synthetic opioids","author":"B Pardo","year":"2019","unstructured":"Pardo B, Taylor J, Caulkins JP, Kilmer B, Reuter P. Stein, B.D. The future of fentanyl and other synthetic opioids. Santa Monica, CA: Rand Corporation; 2019."},{"issue":"10","key":"1460_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.15585\/mmwr.mm7410a3","volume":"74","author":"EW Lundstrom","year":"2025","unstructured":"Lundstrom EW, Macmadu A, Steege AL, Groenewold M. Synthetic opioid and stimulant co-involved overdose deaths by occupation and industry: United States, 2022. MMWR Morb Mortal Wkly Rep. 2025;74(10):173\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1460_CR10","doi-asserted-by":"publisher","first-page":"109428","DOI":"10.1016\/j.drugalcdep.2022.109428","volume":"234","author":"EW Hall","year":"2022","unstructured":"Hall EW, Rosenberg ES, Jones CM, Asher A, Valverde E, Bradley H. Estimated number of injection-involved drug overdose deaths, United States, 2000\u20132018. Drug Alcohol Depend. 2022;234:109428.","journal-title":"Drug Alcohol Depend"},{"key":"1460_CR11","unstructured":"Centers for Disease Control. Persons who inject drugs 2018. Available from https:\/\/www.cdc.gov\/pwid\/index.html"},{"key":"1460_CR12","doi-asserted-by":"crossref","unstructured":"Rigg KK, McLean K, Monnat SM, Sterner GE 3rd, Verdery AM. Opioid misuse initiation: implications for intervention. J Addict Dis. 2018;37(3\u20134):111\u201322.","DOI":"10.1080\/10550887.2019.1609336"},{"issue":"6","key":"1460_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/16066359.2021.1891414","volume":"29","author":"ME Johnson","year":"2021","unstructured":"Johnson ME, Zaidi F. Sex differences in the effects of physical and sexual abuse on the odds of past 30-day opioid misuse among Florida justice-involved children. Addict Res Theory. 2021;29(6):479\u201389.","journal-title":"Addict Res Theory"},{"issue":"5","key":"1460_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ypmed.2012.08.015","volume":"55","author":"SE Hadland","year":"2012","unstructured":"Hadland SE, Werb D, Kerr T, Fu E, Wang H, Montaner JS, et al. Childhood sexual abuse and risk for initiating injection drug use: a prospective cohort study. Prev Med. 2012;55(5):500\u20134.","journal-title":"Prev Med"},{"key":"1460_CR15","doi-asserted-by":"publisher","first-page":"209280","DOI":"10.1016\/j.josat.2023.209280","volume":"160","author":"B Franz","year":"2024","unstructured":"Franz B, Cronin CE, Lindenfeld Z, Pagan JA, Lai AY, Krawczyk N, et al. Rural-urban disparities in the availability of hospital-based screening, medications for opioid use disorder, and addiction consult services. J Subst Use Addict Treat. 2024;160:209280.","journal-title":"J Subst Use Addict Treat"},{"issue":"3","key":"1460_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1037\/rmh0000187","volume":"45","author":"B Showers","year":"2021","unstructured":"Showers B, Dicken D, Smith JS, Hemlepp A. Medication for opioid use disorder in rural America: a review of the literature. J Rural Mental Health. 2021;45(3):184\u201397.","journal-title":"J Rural Mental Health"},{"issue":"5","key":"1460_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1017\/cts.2020.42","volume":"4","author":"DA Morales","year":"2020","unstructured":"Morales DA, Barksdale CL, Beckel-Mitchener AC. A call to action to address rural mental health disparities. J Clin Transl Sci. 2020;4(5):463\u20137.","journal-title":"J Clin Transl Sci"},{"key":"1460_CR18","doi-asserted-by":"publisher","first-page":"116660","DOI":"10.1016\/j.socscimed.2024.116660","volume":"346","author":"TJ Stopka","year":"2024","unstructured":"Stopka TJ, Estadt AT, Leichtling G, Schleicher JC, Mixson LS, Bresett J, et al. Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study. Soc Sci Med. 2024;346:116660.","journal-title":"Soc Sci Med"},{"key":"1460_CR19","doi-asserted-by":"publisher","first-page":"209453","DOI":"10.1016\/j.josat.2024.209453","volume":"165","author":"RJ Fredericksen","year":"2024","unstructured":"Fredericksen RJ, Mixson LS, Estadt AT, Leichtling G, Bresett J, Zule W, et al. Barriers to retention in inpatient and residential drug treatment among persons who use opioids and\/or injection drugs living in the rural U.S. J Subst Use Addict Treat. 2024;165:209453.","journal-title":"J Subst Use Addict Treat"},{"issue":"1","key":"1460_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12954-024-00986-z","volume":"21","author":"RJ Fredericksen","year":"2024","unstructured":"Fredericksen RJ, Baker R, Sibley A, Estadt AT, Colston D, Mixson LS, et al. Motivation and context of concurrent stimulant and opioid use among persons who use drugs in the rural United States: a multi-site qualitative inquiry. Harm Reduct J. 2024;21(1):74.","journal-title":"Harm Reduct J"},{"key":"1460_CR21","doi-asserted-by":"publisher","first-page":"108256","DOI":"10.1016\/j.drugalcdep.2020.108256","volume":"217","author":"K Nolte","year":"2020","unstructured":"Nolte K, Drew AL, Friedmann PD, Romo E, Kinney LM, Stopka TJ. Opioid initiation and injection transition in rural northern New England: A mixed-methods approach. Drug Alcohol Depend. 2020;217:108256.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1460_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1360-0443.2011.03635.x","volume":"107","author":"AM Young","year":"2012","unstructured":"Young AM, Havens JR. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction. 2012;107(3):587\u201396.","journal-title":"Addiction"},{"issue":"8","key":"1460_CR23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/10826080500411577","volume":"41","author":"PJ Draus","year":"2006","unstructured":"Draus PJ, Carlson RG. Needles in the haystacks: the social context of initiation to heroin injection in rural Ohio. Subst Use Misuse. 2006;41(8):1111\u201324.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"1460_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13722-022-00322-5","volume":"17","author":"RA Jenkins","year":"2022","unstructured":"Jenkins RA, Whitney BM, Nance RM, Allen TM, Cooper HLF, Feinberg J, et al. The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis. Addict Sci Clin Pract. 2022;17(1):38.","journal-title":"Addict Sci Clin Pract"},{"key":"1460_CR25","unstructured":"Strauss AJ. C. Grounded theory methodology: an overview. In: Denzin N, editor. Lincoln handbook of qualitative research. 1st ed1994. pp. 273\u2009\u2013\u200984."},{"key":"1460_CR26","doi-asserted-by":"publisher","first-page":"205031211882292","DOI":"10.1177\/2050312118822927","volume":"7","author":"Y Chun Tie","year":"2019","unstructured":"Chun Tie Y, Birks M, Francis K. Grounded theory research: a design framework for novice researchers. SAGE Open Med. 2019;7:2050312118822927.","journal-title":"SAGE Open Med"},{"key":"1460_CR27","first-page":"25","volume-title":"Human development in cultural and historical contexts","author":"U Bronfenbrenner","year":"1988","unstructured":"Bronfenbrenner U. Interacting systems in human development: research paradigms: present and future. Persons in context: developmental processes. Human development in cultural and historical contexts. New York, NY, US: Cambridge University Press; 1988. pp. 25\u201349."},{"issue":"1","key":"1460_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12961-020-00596-8","volume":"18","author":"MS Jalali","year":"2020","unstructured":"Jalali MS, Botticelli M, Hwang RC, Koh HK, McHugh RK. The opioid crisis: a contextual, social-ecological framework. Health Res Policy Syst. 2020;18(1):87.","journal-title":"Health Res Policy Syst"},{"issue":"3","key":"1460_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.31887\/DCNS.2017.19.3\/tcicero","volume":"19","author":"TJ Cicero","year":"2017","unstructured":"Cicero TJ, Ellis MS. The prescription opioid epidemic: a review of qualitative studies on the progression from initial use to abuse. Dialogues Clin Neurosci. 2017;19(3):259\u201369.","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"1460_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13011-022-00480-4","volume":"17","author":"J Dickson-Gomez","year":"2022","unstructured":"Dickson-Gomez J, Krechel S, Spector A, Weeks M, Ohlrich J, Green Montaque HD, et al. The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis. Subst Abuse Treat Prev Policy. 2022;17(1):55.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"1460_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11524-017-0192-8","volume":"95","author":"D Werb","year":"2018","unstructured":"Werb D, Bluthenthal RN, Kolla G, Strike C, Kral AH, Uuskula A, et al. Preventing injection drug use initiation: state of the evidence and opportunities for the future. J Urban Health. 2018;95(1):91\u20138.","journal-title":"J Urban Health"},{"issue":"12","key":"1460_CR32","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1111\/add.13957","volume":"112","author":"A Guise","year":"2017","unstructured":"Guise A, Horyniak D, Melo J, McNeil R, Werb D. The experience of initiating injection drug use and its social context: a qualitative systematic review and thematic synthesis. Addiction. 2017;112(12):2098\u2013111.","journal-title":"Addiction"},{"issue":"Suppl 2","key":"1460_CR33","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1097\/QAI.0000000000000659","volume":"69","author":"J Iversen","year":"2015","unstructured":"Iversen J, Page K, Madden A, Maher L. HIV, HCV, and health-related harms among women who inject drugs: implications for prevention and treatment. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S176\u201381.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1460_CR34","unstructured":"Drug Enforcement Administration. DEA laboratory testing reveals that 6 out of 10 fentanyl-laced fake prescription pills contain a potentially lethal dose of fentanyl; 2024. Available from: https:\/\/www.dea.gov\/alert\/dea-laboratory-testing-reveals-6-out-10-fentanyl-laced-fake-prescription-pills-now-contain"},{"issue":"2","key":"1460_CR35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s40122-023-00481-6","volume":"12","author":"AN Edinoff","year":"2023","unstructured":"Edinoff AN, Martinez Garza D, Vining SP, Vasterling ME, Jackson ED, Murnane KS, et al. New synthetic opioids: clinical considerations and dangers. Pain Ther. 2023;12(2):399\u2013421.","journal-title":"Pain Ther"},{"issue":"6","key":"1460_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.15585\/mmwr.mm7306a2","volume":"73","author":"LJ Tanz","year":"2024","unstructured":"Tanz LJ, Gladden RM, Dinwiddie AT, Miller KD, Broz D, Spector E, et al. Routes of drug use among drug overdose deaths: United States, 2020\u20132022. MMWR Morb Mortal Wkly Rep. 2024;73(6):124\u201330.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"1460_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12954-024-01007-9","volume":"21","author":"R Baker","year":"2024","unstructured":"Baker R, Fredericksen RJ, Rudolph AE, Stopka TJ, Walters SM, Fadanelli M, et al. Overdose responses among rural people who use drugs: a multi-regional qualitative study. Harm Reduct J. 2024;21(1):107.","journal-title":"Harm Reduct J"},{"issue":"26","key":"1460_CR38","doi-asserted-by":"publisher","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","volume":"66","author":"GP Guy Jr","year":"2017","unstructured":"Guy GP Jr., Zhang K, Bohm MK, Losby J, Lewis B, Young R, et al. Vital signs: changes in opioid prescribing in the United States, 2006\u20132015. MMWR Morb Mortal Wkly Rep. 2017;66(26):697\u2013704.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"1460_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","volume":"71","author":"D Dowell","year":"2022","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical practice guideline for prescribing opioids for pain: United States, 2022. MMWR Recomm Rep. 2022;71(3):1\u201395.","journal-title":"MMWR Recomm Rep"},{"key":"1460_CR40","unstructured":"Centers for Disease Control. Opioid dispensing rate maps;2024. Available from: https:\/\/www.cdc.gov\/overdose-prevention\/data-research\/facts-stats\/opioid-dispensing-rate-maps.html"},{"key":"1460_CR41","doi-asserted-by":"publisher","first-page":"109727","DOI":"10.1016\/j.drugalcdep.2022.109727","volume":"242","author":"CN Maierhofer","year":"2023","unstructured":"Maierhofer CN, Ranapurwala SI, DiPrete BL, Fulcher N, Ringwalt CL, Chelminski PR, et al. Intended and unintended consequences: Changes in opioid prescribing practices for postsurgical, acute, and chronic pain indications following two policies in North Carolina, 2012\u20132018 - Controlled and single-series interrupted time series analyses. Drug Alcohol Depend. 2023;242:109727.","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"1460_CR42","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1377\/hlthaff.2019.00722","volume":"38","author":"G Gong","year":"2019","unstructured":"Gong G, Phillips SG, Hudson C, Curti D, Philips BU. Higher US rural mortality rates linked to socioeconomic status, physician shortages, and lack of health insurance. Health Aff (Millwood). 2019;38(12):2003\u201310.","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"1460_CR43","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/JOM.0b013e3181917d8e","volume":"51","author":"AE Young","year":"2009","unstructured":"Young AE, Cifuentes M, Wasiak R, Webster BS. Urban-rural differences in work disability following occupational injury: are they related to differences in healthcare utilization? J Occup Environ Med. 2009;51(2):204\u201312.","journal-title":"J Occup Environ Med"},{"issue":"6","key":"1460_CR44","first-page":"qxad070","volume":"1","author":"SND Negaro","year":"2023","unstructured":"Negaro SND, Hantman RM, Probst JC, Crouch EL, Odahowski CL, Andrews CM, et al. Geographic variations in driving time to US mental health care, digital access to technology, and household crowdedness. Health Aff Sch. 2023;1(6):qxad070.","journal-title":"Health Aff Sch"},{"issue":"8","key":"1460_CR45","doi-asserted-by":"publisher","first-page":"e2226544","DOI":"10.1001\/jamanetworkopen.2022.26544","volume":"5","author":"PT Korthuis","year":"2022","unstructured":"Korthuis PT, Cook RR, Foot CA, Leichtling G, Tsui JI, Stopka TJ, et al. Association of methamphetamine and opioid use with nonfatal overdose in rural communities. JAMA Netw Open. 2022;5(8):e2226544.","journal-title":"JAMA Netw Open"},{"key":"1460_CR46","unstructured":"Substance use in women research report: sex and gender differences in substance abuse. National Institute on Drug Abuse. 2020. Contract No.: April 25, 2024."},{"issue":"5","key":"1460_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/00952990.2011.596982","volume":"37","author":"SE Back","year":"2011","unstructured":"Back SE, Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L, et al. Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse. 2011;37(5):313\u201323.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"1460_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1176\/appi.prcp.20190051","volume":"3","author":"C Barbosa-Leiker","year":"2021","unstructured":"Barbosa-Leiker C, Campbell ANC, McHugh RK, Guille C, Greenfield SF. Opioid use disorder in women and the implications for treatment. Psychiatr Res Clin Pract. 2021;3(1):3\u201311.","journal-title":"Psychiatr Res Clin Pract"},{"key":"1460_CR49","doi-asserted-by":"publisher","first-page":"108182","DOI":"10.1016\/j.drugalcdep.2020.108182","volume":"215","author":"BA Reboussin","year":"2020","unstructured":"Reboussin BA, Rabinowitz JA, Thrul J, Maher B, Green KM, Ialongo NS. Trajectories of cannabis use and risk for opioid misuse in a young adult urban cohort. Drug Alcohol Depend. 2020;215:108182.","journal-title":"Drug Alcohol Depend"},{"key":"1460_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.drugalcdep.2015.11.029","volume":"159","author":"BJ Arterberry","year":"2016","unstructured":"Arterberry BJ, Horbal SR, Buu A, Lin HC. The effects of alcohol, cannabis, and cigarette use on the initiation, reinitiation and persistence of non-medical use of opioids, sedatives, and tranquilizers in adults. Drug Alcohol Depend. 2016;159:86\u201392.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1460_CR51","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jadohealth.2012.06.010","volume":"52","author":"LE Fiellin","year":"2013","unstructured":"Fiellin LE, Tetrault JM, Becker WC, Fiellin DA, Hoff RA. Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults. J Adolesc Health. 2013;52(2):158\u201363.","journal-title":"J Adolesc Health"},{"issue":"Suppl 10 1","key":"1460_CR52","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1007\/s11121-012-0296-z","volume":"15","author":"SG Kellam","year":"2014","unstructured":"Kellam SG, Wang W, Mackenzie AC, Brown CH, Ompad DC, Or F, et al. The impact of the Good Behavior Game, a universal classroom-based preventive intervention in first and second grades, on high-risk sexual behaviors and drug abuse and dependence disorders into young adulthood. Prev Sci. 2014;15(Suppl 10 1):S6\u201318.","journal-title":"Prev Sci"},{"key":"1460_CR53","unstructured":"Facing addiction in America. The surgeon general\u2019s report on alcohol, drugs, and health. reports of the surgeon general. Washington (DC)2016."},{"issue":"3","key":"1460_CR54","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.chc.2010.03.005","volume":"19","author":"KW Griffin","year":"2010","unstructured":"Griffin KW, Botvin GJ. Evidence-based interventions for preventing substance use disorders in adolescents. Child Adolesc Psychiatr Clin N Am. 2010;19(3):505\u201326.","journal-title":"Child Adolesc Psychiatr Clin N Am"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01460-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01460-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01460-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:04:35Z","timestamp":1782176675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01460-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01460-8","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies had local institutional review board approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}